Delivery Order SPE2DR25D1021-SPE2DR26FNN1D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Jadenu 360 mg tablets (30-count units) with a ceiling value of $20,184.03. This firm fixed-price delivery order, which is scheduled for completion by October 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The award was made through...
- The Defense Logistics Agency awarded a $17,333.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for JADENU 360 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $40,176.29 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of JADENU 360 mg tablets (30-count packages). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $84,982.81 to AmerisourceBergen Drug Corp for the supply of Jadenu 360 mg tablets (30-count units) on October 15, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $12,031.54 delivery order to AmerisourceBergen Drug Corp for Jadenu 360 mg tablets (30-count units) on October 24, 2025, with an ultimate completion date of October 27, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp received a $37,524.35 delivery order from the Defense Logistics Agency (DLA) on July 17, 2025, for the supply of Jadenu 360 mg tablets (30-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jadenu is an iron chelation therapy medication used to treat chronic iron overload, a condition common...
- The Defense Logistics Agency awarded a delivery order valued at $21,735.08 to AmerisourceBergen Drug Corp for JADENU 360 mg tablets (30-count) on October 30, 2025, with completion scheduled for October 31, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,625.87 fixed-price delivery order is for the supply of JADENU 360 MG TABLET 30S, a pharmaceutical product, with a performance period through March 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $28,728.06, is for the supply of JADENU 360 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of October 16, 2024 and was made on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,062.11 to AmerisourceBergen Drug Corp for the supply of JADENU 360 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNN1DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $25,105.23 to AmerisourceBergen Drug Corp for JADENU 360 mg tablets (30-count packages) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies critical medical commodities to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's contract portfolio demonstrates consistent success in competitively awarded delivery orders across diverse therapeutic domains, ranging from specialty medications and vaccines to medical devices and supplies. This particular delivery order for JADENU, an iron chelation therapy medication, reflects the contractor's role as a strategic supplier for military medical logistics and supports the broader DLA mission to maintain adequate pharmaceutical inventories across the defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.1k | 11/20/25 |